Trial Profile
Clinical Trials Insight: 700035258
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 May 2009
Price :
$35
*
At a glance
- Drugs Clevudine (Primary)
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Sponsors Pharmasset
- 26 Apr 2009 Reults reported at the 44th Annual Meeting of the European Association for the Study of the Liver.
- 14 Jul 2008 New trial record.